Anke Biotechnology (300009CH) Vs Changchun High & New Tech (000661CH)-Growth Hormone VBP and Outlook
We analyzed the impact and outlook of growth hormone VBP that led to share price plunge of Anke and CCHT. We also analyzed the bidding strategy for...
419 Views
Changchun High & New Tech (000661.CH) - Logic Change?
The article analyzed Changchun High & New Tech in terms of its 2021/1H financial results,media exposure of growth hormone abuse, possibility of...
336 Views
Changchun High & New Tech (000661.CH) - Insights on Recent Pullback & The Future Business Outlook
This article mainly analyzed potential reasons for recent pullback: the possibility of volume-based purchase and major shareholder's reduction of...
328 Views
I-Mab (IMAB US) - Insights On Core Products TJC4, TJ202 and TJ101
As I-MAB has come to a key phase from R&D to commercialization, this article analyzed both the strength and the concerns for its core products...
390 Views
PICC P&C – Still Too Much Credit
*Weak 1H20 Results: PICCÂ P&CÂ (2328.HK) [PICC P&C] reported 1H20 earnings of CNY 13.2 bn, which was 6% below consensus and down 22% YOY....
393 Views